Chantix has been a popular smoking cessation aid for years, but has recently been called the most dangerous brand name drug on the market today due to its high risk of serious psychological side effects. Depression is one of the most common reasons for a Chantix lawsuit, and can get severe enough in some patients that they begin to consider or attempt suicide. In some cases, patients can start experiencing rapidly escalating depression symptoms within two days of starting treatment with Chantix. On the other hand, though, Chantix-related depression can sometimes stop once the drug stops being consumed by the patient. Unfortunately, this is not always the case, and some symptoms can remain after the drug is no longer being taken.
Although studies have not yet found the scientific cause of Chantix-related depression, there are some theories as to why it could occur. Some postulate that patients who already have a chemical imbalance might experience worsening of it or a manifestation of it that has not happened before due to Chantix blocking dopamine receptors in the brain. Others suggest that smoking and psychiatric disorders could be linked, meaning that Chantix has little or nothing to do with the psychological symptoms patients are experiencing. Scientists are still pursuing the actual cause of these conditions and will hopefully soon come forward with an answer.
Over 10,000 Chantix patients have reported psychological side effects related to Chantix, leading to over 1,200 patients coming forward to file suit against the drug. The Food and Drug Administration has required strict amounts of warnings to be provided on Chantix packaging and prescription inserts due to the high risk of psychological side effects in Chantix patients, as well as other side effects such as Stevens-Johnson Syndrome and diabetes, both of which have a tentative link to Chantix.